header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-285
Fish name: foxi1em1/em1
Genotype: foxi1em1/em1
Targeting Reagent: none
HUMAN DISEASE MODELED by foxi1em1/em1
No data available
GENE EXPRESSION
Gene expression in foxi1em1/em1
RNA expression
Expressed Gene Structure Conditions Figures
atoh1b control Fig. 2 with image from Hans et al., 2013
cdh6 control Fig. 2 with image from Hans et al., 2013
crestin standard conditions Fig. 8 with image from Solomon et al., 2003
dlx2a standard conditions Fig. 8 with image from Solomon et al., 2003
dlx3b standard conditions Fig. 5 with imageFig. 7 with image from Solomon et al., 2003
dlx4b standard conditions Fig. 7 with image from Solomon et al., 2003
dlx5a standard conditions Fig. 7 with image from Solomon et al., 2003
foxi1 standard conditions Fig. 8 with image from Solomon et al., 2003
hmx3a control Fig. 2 with image from Hans et al., 2013
myo7aa control Fig. 2 with image from Hans et al., 2013
neurod1 control Fig. 2 with image from Hans et al., 2013
otx2b control Fig. 8 with image from Hans et al., 2007
chemical treatment: all-trans-retinoic acid Fig. 8 with image from Hans et al., 2007
pax2a standard conditions Fig. 3 with image from Schwarzer et al., 2017
Fig. S1 with image from Nechiporuk et al., 2007
Fig. 5 with image from Solomon et al., 2003
pax8 standard conditions Fig. 3 with image from Schwarzer et al., 2017
Fig. 8 with image from Hans et al., 2007
Fig. 5 with image from Solomon et al., 2003
sox9a standard conditions Fig. 3 with image from Schwarzer et al., 2017
stm standard conditions Fig. 2 with image from Schwarzer et al., 2017
Fig. 2 with image from Hans et al., 2013
tbx1 control Fig. 2 with image from Hans et al., 2013
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in foxi1em1/em1
Phenotype Conditions Figures
auditory capsule hypoplastic, abnormal chemical treatment: ethanol Fig. 7 from Swartz et al., 2014
ceratobranchial cartilage decreased amount, abnormal standard conditions Fig. 7 from Swartz et al., 2014
ceratobranchial cartilage hypoplastic, abnormal chemical treatment: ethanol Fig. 7 from Swartz et al., 2014
ceratohyal cartilage decreased length, abnormal standard conditions Fig. 8 with image from Solomon et al., 2003
ceratohyal cartilage displaced, abnormal standard conditions Fig. 7 from Swartz et al., 2014
ceratohyal cartilage hypoplastic, abnormal chemical treatment: ethanol Fig. 7 from Swartz et al., 2014
ceratohyal cartilage increased thickness, abnormal standard conditions Fig. 8 with image from Solomon et al., 2003
ceratohyal cartilage orientation ceratohyal cartilage, abnormal standard conditions Fig. 8 with image from Solomon et al., 2003
cranial nerve neuron projection displaced, abnormal chemical treatment: ethanol Fig. 8 from Swartz et al., 2014
cranial nerve neuron projection physical object quality, abnormal chemical treatment: ethanol Fig. 8 from Swartz et al., 2014
embryonic viscerocranium morphogenesis disrupted, abnormal standard conditions Fig. 1 with imageFig. 8 with image from Solomon et al., 2003
hyosymplectic cartilage aplastic, abnormal chemical treatment: ethanol Fig. 7 from Swartz et al., 2014
hyosymplectic cartilage malformed, abnormal standard conditions Fig. 7 from Swartz et al., 2014
mandibular arch skeleton decreased size, abnormal standard conditions Fig. 1 with image from Solomon et al., 2003
mouth structure, abnormal standard conditions Fig. 1 with image from Solomon et al., 2003
otic epithelium stm expression decreased distribution, abnormal standard conditions Fig. 2 with image from Schwarzer et al., 2017
otic placode pax8 expression absent, abnormal standard conditions Fig. 3 with image from Schwarzer et al., 2017
otic placode pax2a expression absent, abnormal standard conditions Fig. 3 with image from Schwarzer et al., 2017
otic placode sox9a expression decreased distribution, abnormal standard conditions Fig. 3 with image from Schwarzer et al., 2017
otic placode pax2a expression decreased distribution, abnormal standard conditions Fig. 3 with image from Schwarzer et al., 2017
otic vesicle decreased size, abnormal standard conditions Fig. 2 with image from Hans et al., 2013
Fig. 1 with image from Solomon et al., 2003
otic vesicle has fewer parts of type immature macula, abnormal control Fig. 2 with image from Hans et al., 2013
otic vesicle morphology, abnormal standard conditions Fig. 2 with image from Schwarzer et al., 2017
otic vesicle inner ear receptor cell differentiation process quality, normal control Fig. 2 with image from Hans et al., 2013
otic vesicle neuroblast (sensu Vertebrata) poorly differentiated, abnormal control Fig. 2 with image from Hans et al., 2013
otic vesicle neuron differentiation decreased process quality, abnormal control Fig. 2 with image from Hans et al., 2013
otic vesicle development disrupted, abnormal standard conditions Fig. 1 with image from Solomon et al., 2003
otic vesicle morphogenesis decreased process quality, abnormal control Fig. 2 with image from Hans et al., 2013
pharyngeal arch morphology, abnormal standard conditions Fig. 8 with image from Solomon et al., 2003
pharyngeal arch anterior-posterior axis decreased length, abnormal standard conditions Fig. 8 with image from Solomon et al., 2003
pharyngeal arch 3-7 orientation whole organism anterior-posterior axis, abnormal standard conditions Fig. 8 with image from Solomon et al., 2003
vagal neural crest decreased distance hyoid neural crest, abnormal standard conditions Fig. 8 with image from Solomon et al., 2003
whole organism lacks parts or has fewer parts of type otic vesicle, abnormal standard conditions Fig. 1 with image from Solomon et al., 2003
whole organism viability, abnormal standard conditions text only from Solomon et al., 2003

CITATIONS  (8)